IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 70 filers reported holding IVERIC BIO INC in Q4 2019. The put-call ratio across all filers is 0.12 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,258,000 | -55.8% | 175,000 | -61.1% | 1.26% | -69.4% |
| Q4 2022 | $9,635,000 | +2.3% | 450,000 | -14.3% | 4.11% | +55.6% |
| Q3 2022 | $9,419,000 | +95.8% | 525,000 | +5.0% | 2.64% | +5.5% |
| Q2 2022 | $4,810,000 | -36.5% | 500,000 | +11.1% | 2.50% | +52.4% |
| Q1 2022 | $7,574,000 | -27.5% | 450,000 | -28.0% | 1.64% | -56.1% |
| Q4 2021 | $10,450,000 | -11.2% | 625,000 | -13.8% | 3.74% | +8.8% |
| Q3 2021 | $11,774,000 | +157.4% | 725,000 | 0.0% | 3.44% | +173.7% |
| Q2 2021 | $4,575,000 | -34.2% | 725,000 | -35.6% | 1.26% | -23.0% |
| Q1 2021 | $6,953,000 | -26.8% | 1,125,000 | -18.2% | 1.63% | -22.8% |
| Q4 2020 | $9,501,000 | +68.5% | 1,375,000 | +37.5% | 2.12% | +29.9% |
| Q3 2020 | $5,640,000 | +22.9% | 1,000,000 | +11.1% | 1.63% | +34.6% |
| Q2 2020 | $4,590,000 | +61.1% | 900,000 | +8.6% | 1.21% | +60.2% |
| Q1 2020 | $2,850,000 | -55.7% | 828,459 | +10.5% | 0.76% | -38.3% |
| Q4 2019 | $6,435,000 | – | 750,000 | – | 1.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |